Original price was: ₹197.50.₹167.00Current price is: ₹167.00.
Remo MV 500 Tablet
Marketer: Glenmark Pharmaceuticals Ltd
Salt Composition: Remogliflozin Etabonate 100 mg + Vildagliptin 50 mg + Metformin 500 mg
10.0 tablets in 1 strip
Description
Remo MV 500 Tablet is a triple-action antidiabetic medication for patients with type 2 diabetes mellitus who need better glycemic control. It contains:
-
Remogliflozin Etabonate 100 mg – an SGLT2 inhibitor that increases urinary glucose excretion, helping lower blood sugar levels.
-
Vildagliptin 50 mg – a DPP-4 inhibitor that enhances insulin secretion and reduces post-meal glucagon levels, improving postprandial glucose control.
-
Metformin 500 mg – a biguanide that reduces hepatic glucose production and improves insulin sensitivity.
By acting on multiple pathways of blood glucose regulation, this combination ensures better glycemic control, weight management, and reduced risk of diabetes-related complications.
Uses of Remo MV 500 Tablet
-
Management of type 2 diabetes mellitus
-
Helps lower fasting and postprandial blood sugar
-
Supports weight management in overweight diabetic patients
-
Suitable when dual therapy is insufficient
-
Reduces risk of hyperglycemia-related complications
How to Use
-
Take exactly as prescribed by your doctor, usually once or twice daily.
-
Swallow the tablet whole with water, preferably with meals to reduce gastrointestinal discomfort.
-
Monitor blood sugar levels regularly.
-
Maintain a diabetic diet, exercise, and lifestyle modifications for optimal results.
Side Effects
Common:
-
Gastrointestinal upset (nausea, diarrhea, abdominal discomfort)
-
Increased urination or mild dehydration
-
Headache or dizziness
Less common but serious:
-
Lactic acidosis (rare, related to Metformin)
-
Severe urinary tract infections
-
Hypoglycemia (especially if combined with other antidiabetic medications)
-
Ketoacidosis – seek immediate medical attention
Precautions & Warnings
-
Prescription Required – use only under medical supervision.
-
Inform your doctor about kidney, liver, or heart conditions before starting therapy.
-
Maintain adequate hydration to prevent dehydration.
-
Not recommended during pregnancy or breastfeeding unless prescribed.
-
Regular blood sugar and kidney function monitoring is advised.
-
Report unexplained fatigue, severe abdominal pain, or unusual muscle pain immediately.
Conclusion
Remo MV 500 Tablet (Remogliflozin Etabonate 100 mg + Vildagliptin 50 mg + Metformin 500 mg) is a triple-action antidiabetic therapy that effectively lowers blood sugar, improves glycemic control, and supports weight management. When used under medical supervision with diet and lifestyle measures, it provides comprehensive management of type 2 diabetes and helps prevent long-term complications.






